Omada Health, Inc. (OMDA) Guidance & Earnings Results
On 2026-05-07 Omada Health, Inc. raised guidance: "Revenue guidance raised from $312M-$322M to $322M-$330M; adjusted EBITDA guidance raised from $7M-$15M to…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OMDAOmada Health, Inc.Follow OMDA — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 7 May 26 | Raised | Revenue guidance raised from $312M-$322M to $322M-$330M; adjusted EBITDA guidance raised from $7M-$15M to $14M-$20M · full year |
| 5 Mar 26 | Raised | FY2026 revenue $312-322M (22% growth at midpoint); adjusted EBITDA $7-15M |
| 7 Aug 25 | Raised | FY25 revenue $235-241M; adjusted EBITDA loss $9-5M · full year |
Omada Health, Inc. — questions
- What guidance did Omada Health, Inc. give?
- On 2026-05-07: "Revenue guidance raised from $312M-$322M to $322M-$330M; adjusted EBITDA guidance raised from $7M-$15M to $14M-$20M"
- When does Omada Health, Inc. report earnings?
- Omada Health, Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from Omada Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.